Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 85
- Labeller names
- 3
- Live patents
- 0
- Shortage listings
- 12
- Countries
- 0
Alert
Drug shortage listings
12| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01) | Current | Available | 12 Oct 20222 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01) | Current | Available | 12 Oct 20222 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01) | Current | Available | 12 Oct 20222 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01) | Current | Available | 12 Oct 20222 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01) | Current | Available | 12 Oct 20222 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Current | Available | 14 Jul 20232 Oct 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Current | Available | 14 Jul 20232 Oct 2026 |
Catalogue
Drug listings by form and route
8585 active NDC listings: 85 human prescription drug. By marketing category: ANDA 63, NDA 18, NDA AUTHORIZED GENERIC 4.
| Dosage form | NDCs |
|---|---|
| tablet | 31 |
| capsule | 19 |
| tablet, extended release | 8 |
| capsule, extended release | 6 |
| patch | 5 |
| film | 4 |
| injection, solution | 4 |
| patch, extended release | 4 |
| tablet, film coated, extended release | 2 |
| cream | 1 |
| powder, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 67 |
| transdermal | 9 |
| buccal | 4 |
| sublingual | 4 |
| intramuscular | 2 |
| subcutaneous | 2 |
| vaginal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| alvogen inc. | 48 |
| alvogen, inc. | 32 |
| alvogen | 5 |
Catalogue
Marketed products
85| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Bonsity | teriparatide | injection, solution, subcutaneous | 47781-852NDA |
| Buprenorphine and Naloxone Sublingual Film | Buprenorphine and Naloxone | film, buccal, sublingual | 47781-355ANDA |
| Buprenorphine and Naloxone Sublingual Film | Buprenorphine and Naloxone | film, buccal, sublingual | 47781-356ANDA |
| Buprenorphine and Naloxone Sublingual Film | Buprenorphine and Naloxone | film, buccal, sublingual | 47781-357ANDA |
| Buprenorphine and Naloxone Sublingual Film | Buprenorphine and Naloxone | film, buccal, sublingual | 47781-358ANDA |
| Dexamethasone | dexamethasone | tablet, oral | 47781-914ANDA |
| Dexamethasone | dexamethasone | tablet, oral | 47781-916ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 mg,Cll | tablet, oral | 47781-174ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 10 mg,Cll | tablet, oral | 47781-176ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 15 mg,Cll | tablet, oral | 47781-178ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 20 mg,Cll | tablet, oral | 47781-179ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 30 mg,Cll | tablet, oral | 47781-180ANDA |
| Disulfiram | Disulfiram | tablet, oral | 47781-607ANDA |
| Estradiol | Estradiol | cream, vaginal | 47781-104ANDA |
| Fentanyl system | Fentanyl | patch, transdermal | 47781-423ANDA |
| Fentanyl system | Fentanyl | patch, transdermal | 47781-424ANDA |
| Fentanyl system | Fentanyl | patch, transdermal | 47781-426ANDA |
| Fentanyl system | Fentanyl | patch, transdermal | 47781-427ANDA |
| Fentanyl system | Fentanyl | patch, transdermal | 47781-428ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-392ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-393ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-394ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-395ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-396ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-397ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | tablet, extended release, oral | 47781-398ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-409ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-410ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-411ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-412ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-413ANDA |
| Hydrocodone Bitartrate | Hydrocodone Bitartrate | capsule, extended release, oral | 47781-414ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-483ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-484ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-485ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-486ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-487ANDA |
| LENALIDOMIDE | Lenalidomide | capsule, oral | 47781-488ANDA |
| Methenamine Hippurate | Methenamine Hippurate | tablet, oral | 47781-577NDA |
| Naproxen Sodium | Naproxen Sodium | tablet, film coated, extended release, oral | 47781-153NDA AUTHORIZED GENERIC |
| Naproxen Sodium | Naproxen Sodium | tablet, film coated, extended release, oral | 47781-154NDA AUTHORIZED GENERIC |
| Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/Macrocrystalline | capsule, oral | 47781-303NDA |
| Oseltamivir Phosphate | Oseltamivir phosphate | capsule, oral | 47781-468ANDA |
| Oseltamivir Phosphate | Oseltamivir phosphate | capsule, oral | 47781-469ANDA |
| Oseltamivir Phosphate | Oseltamivir phosphate | capsule, oral | 47781-470ANDA |
| Oseltamivir Phosphate for Oral Suspension | Oseltamivir Phosphate | powder, for suspension, oral | 47781-384ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 47781-196ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 47781-229ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 47781-230ANDA |
| Oxycodone hydrochloride | Oxycodone hydrochloride | tablet, oral | 47781-263ANDA |
| Oxycodone hydrochloride | Oxycodone hydrochloride | tablet, oral | 47781-264ANDA |
| Oxycodone hydrochloride | Oxycodone hydrochloride | tablet, oral | 47781-265ANDA |
| Pyridostigmine Bromide | Pyridostigmine Bromide | tablet, extended release, oral | 47781-335ANDA |
| Rasagiline | Rasagiline | tablet, oral | 47781-683ANDA |
| Rasagiline | Rasagiline | tablet, oral | 47781-690ANDA |
| buprenorphine transdermal system | buprenorphine | patch, extended release, transdermal | 47781-406ANDA |
| buprenorphine transdermal system | buprenorphine | patch, extended release, transdermal | 47781-407ANDA |
| buprenorphine transdermal system | buprenorphine | patch, extended release, transdermal | 47781-408ANDA |
| buprenorphine transdermal system | buprenorphine | patch, extended release, transdermal | 47781-419ANDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-640NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-643NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-646NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-649NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-651NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-654NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-657NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-659NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-662NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-665NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-668NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-671NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-721NDA |
| levothyroxine sodium | levothyroxine sodium | tablet, oral | 47781-728NDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-562ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-563ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-564ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-565ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-566ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-567ANDA |
| lisdexamfetamine dimesylate | lisdexamfetamine dimesylate | capsule, oral | 47781-568ANDA |
| sertraline hydrochloride | sertraline hydrochloride | capsule, oral | 47781-951NDA AUTHORIZED GENERIC |
| sertraline hydrochloride | sertraline hydrochloride | capsule, oral | 47781-962NDA AUTHORIZED GENERIC |
| teriparatide | teriparatide | injection, solution, subcutaneous | 47781-652NDA |
| testosterone cypionate | testosterone cypionate | injection, solution, intramuscular | 47781-910ANDA |
| testosterone cypionate | testosterone cypionate | injection, solution, intramuscular | 47781-911ANDA |
Compare
Other companies listing levothyroxine sodium
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Preferred Pharmaceuticals Inc.1 site · 1,046 NDC
- Camber Pharmaceuticals, Inc.1 site · 640 NDC
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Northwind Health Company, LLC1 site · 580 NDC
Enquiry
Common questions
- Is Alvogen, Inc. FDA approved?
- Alvogen, Inc. holds no registered establishment of its own; 85 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Alvogen, Inc. make?
- 85 products are listed under Alvogen, Inc. in the openFDA NDC Directory, most often as tablet; capsule; tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Alvogen, Inc. products in shortage?
- 12 presentations are currently listed in the FDA drug shortage database under Alvogen, Inc., covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet, Lisdexamfetamine Dimesylate Capsule.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.